European Society for Organ Transplantation

EU Legislative Interests

Improving Integrated people-centered Health Care Solutions (INCASO) Improving Organ Donation and Transplantation in the EU

Communication Activities

Development of ESOT Manifesto 2023-25 Participation to Gastein Health Forum 2022 Participation to Santander Summit 2023 Member of the European Public Health Alliance Observer in the Council of Europe - CDPTO Observer in the SoHo of the ECDC Member of the European Kidney Health Alliance Eligible organisation by European Medicines Agency

Interests Represented

Promotes their own interests or the collective interests of their members

Member Of

European Public Health Alliance (EPHA) European Kidney Health Alliance (EKHA)

Organisation Members

EU Health Coalition European Kidney Health Alliance Observer at CDPTO Observer in SoHo Group of the ECDC

Additional Information

EU4Health – Building Resilience Against crisis: a systematic and global approach to adVancE organ Safety and supply in Transplantation ESOT coordinates BRAVEST, a European Funding Research Project under the EU4 Health programme. The project aims to analyse the factors that have influenced the organ procurement processes before, during and after the onset of the SARS-CoV2 pandemic, as a paradigm of the resilience of the donor procurement network in ensuring safety and continuity of supply of organ donation. https://www.bravest-project.eu/ HORUS - ORUS involves the first longitudinal cohort of European SOT recipients. In a sub-‘HORUS-exploratory cohort’, we will perform a thorough investigation of viral, clinical and immunological characteristics. Combining those parameters will provide a signature early after transplantation to predict the risk of developing CMV infection and a signature at Day 0 of infection to predict the risk of CMV disease severity. This signature will then be validated retrospectively by the whole cohort and prospectively in a ‘proof-of-concept’ study. Moreover, HORUS will include functional in vitro and mouse models to investigate the mechanisms of lymphocyte response to CMV and provide innovative methods to increase CMV-specific immunity. Altogether, HORUS will enhance personalised clinical prevention and the treatment of CMV disease, ultimately improving patient outcomes. https://www.horus-project.eu/project LEOPARD https://www.leopard-project.eu/ The LEOPARD project seeks to enhance liver transplantation outcomes by creating and validating an AI-based predictive algorithm, considering recently identified predictors, that surpasses current models in stratifying both DC and HCC patients by mortality/dropout risks on the waitlist. Additionally, the project will develop calculators for DC and HCC candidates to aid in patient prioritisation, as well as integrate predictive signatures from OMICs/radiomics to improve risk assessmen